Current trends in translational research in leptospirosis

Current Opinion in Infectious Diseases

Volumn 26, Issue 5, 2013, Pages 399-403

  Ricaldi, Jessica N ^a,c   Swancutt, Mark A ^b   Matthias, Michael A ^c  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

leptospirosis; translational; zoonosis

Indexed keywords

AMPICILLIN; CEPHALOSPORIN DERIVATIVE; DOXYCYCLINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PENICILLIN DERIVATIVE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADAPTIVE IMMUNITY; DENDRITIC CELL; GOLD STANDARD; HUMAN; IMMUNE RESPONSE; LEPTOSPIROSIS; POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; TRANSLATIONAL RESEARCH; TREND STUDY;

ANIMALS; HUMANS; LEPTOSPIROSIS; TRANSLATIONAL MEDICAL RESEARCH; ZOONOSES;

EID: 84883597848     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000001     Document Type: Review

References (55)

1. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003; 3:757-771.
2. Leptospirosis Burden Epidemiology Reference Group (LBERG). The global burden of leptospirosis. 2013; WHO website. http://www.who.int/zoonoses/ diseases/lerg/en/index2.html. [Accessed 22 June 2013]
3. Reis RB, Ribeiro GS, Felzemburgh RDM, et al. Impact of environment and social gradient on leptospira infection in urban slums. PLoS Negl Trop Dis 2008; 2:e228.
4. Levett PN. Leptospirosis. Clin Microbiol Rev 2001; 14:296-326.
5. Limmathurotsakul D, Turner EL,Wuthiekanun V, et al. Fool's gold: why imperfect reference tests are undermining the evaluation of novel diagnostics-a reevaluation of 5 diagnostic tests for leptospirosis. Clin Infect Dis 2012; 55:322-331.
6. Blanco RM, Romero EC. Efficacy of serum samples stored on filter paper for the detection of antibody to Leptospira spp. by microagglutination test (MAT). J Immunol Methods 2012; 386:31-33.
7. Desakorn V, Wuthiekanun V, Thanachartwet V, et al. Accuracy of a commercial IgM ELISA for the diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg 2012; 86:524-527.
8. Signorini ML, Lottersberger J, Tarabla HD, et al. Enzyme-linked immunosorbent assay to diagnose human leptospirosis: a meta-analysis of the published literature. Epidemiol Infect 2013; 141:22-32.
9. Nabity SA, Ribeiro GS, Aquino CL, et al. Accuracy of a dual path platform (DPP) assay for the rapid point-of-care diagnosis of human leptospirosis. PLoS Negl Trop Dis 2012; 6:e1878.
10. Agampodi SB, Peacock SJ, Thevanesam V, et al. Leptospirosis outbreak in Sri Lanka in 2008: lessons for assessing the global burden of disease. Am J Trop Med Hyg 2011; 85:471-478.
11. Agampodi SB, Matthias MA, Moreno AC, et al. Utility of quantitative polymerase chain reaction in leptospirosis diagnosis: association of level of leptospiremia and clinical manifestations in Sri Lanka. Clin Infect Dis 2012; 54:1249-1255.
12. Agampodi SB, Moreno AC, Vinetz JM, et al. Utility and limitations of direct multilocus sequence typing on qPCR-positive blood to determine infecting Leptospira strain. Am J Trop Med Hyg 2013; 88:184-185.
13. Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev 2012; 2:CD008264.
14. Suputtamongkol Y, Niwattayakul K, Suttinont C, et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004; 39:1417-1424.
15. Panaphut T, Domrongkitchaiporn S, Vibhagool A, et al. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 2003; 36:1507-1513.
16. Brett-Major DM, Lipnick RJ. Antibiotic prophylaxis for leptospirosis. Cochrane Database Syst Rev 2009; CD007342.
17. Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 310:497-500.
18. Mart́nez R, Pé rez A, Quiñones M, et al. Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba [efficacy and safety of a human leptospirosis vaccine in Cuba]. Revista Panamericana de Salud Pú blica/Pan American Journal 2004; 15:249-255.
19. He HJ, Wang WY, Wu ZD, et al. Protection of guinea pigs against Leptospira interrogans serovar Lai by LipL21 DNA vaccine. Cell Mol Immunol 2008; 5:385-391.
20. Cerqueira GM, McBride AJ, Picardeau M, et al. Distribution of the leptospiral immunoglobulin-like (lig) genes in pathogenic Leptospira species and application of ligB to typing leptospiral isolates. J Med Microbiol 2009; 58:1173-1181.
21. Truccolo J, Serais O, Merien F, et al. Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay. FEMS Microbiol Lett 2001; 204:317-321.
22. Wagenaar JF, Gasem MH, Goris MG, et al. Soluble ST2 levels are associated with bleeding in patients with severe leptospirosis. PLoS Negl Trop Dis 2009; 3:e453.
23. Croda J, Neto AN, Brasil RA, et al. Leptospirosis pulmonary haemorrhage syndrome is associated with linear deposition of immunoglobulin and complement on the alveolar surface. Clin Microbiol Infect 2010; 16:593-599.
24. Nally JE, Chantranuwat C, Wu XY, et al. Alveolar septal deposition of immunoglobulin and complement parallels pulmonary hemorrhage in a guinea pig model of severe pulmonary leptospirosis. Am J Pathol 2004; 164:1115-1127.
25. Verma A, Rathinam SR, Priya CG, et al. LruA and LruB antibodies in sera of humans with leptospiral uveitis. Clin Vaccine Immunol 2008; 15:1019-1023.
26. Estavoyer JM, Racadot E, Couetdic G, et al. Tumor necrosis factor in patients with leptospirosis. Rev Infect Dis 1991; 13:1245-1246.
27. Wang H, Wu Y, Ojcius DM, et al. Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-kappaB signaling pathways. PLoS One 2012; 7:e42266.
28. Jongyota W, Wigraipat C, Nontapa S, et al. Differential response of cytokines induced by Leptospira interrogans, serogroup Pomona, serovar Pomona, in mouse and human cell lines. Asian Pac J Allergy Immunol 2008; 26:229-236.
29. Klimpel GR, Matthias MA, Vinetz JM. Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta\+ T cells vs TCR alpha beta\+ T cells. J Immunol 2003; 171:1447-1455.
30. Tajiki H, Salomao R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis 1996; 23:1177-1178.
31. Vernel-Pauillac F, Goarant C. Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis 2010; 4:e582.
32. Werts C, Tapping RI, Mathison JC, et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2:346-352.
33. GorisMG, Wagenaar JF, Hartskeerl RA, et al. Potent innate immune response to pathogenic leptospira in human whole blood. PLoS One 2011; 6:e18279.
34. Viriyakosol S, Matthias MA, Swancutt MA, et al. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun 2006; 74:887-895.
35. Werts C. Leptospirosis: a toll road from B lymphocytes. Chang Gung Med J 2010; 33:591-601.
36. Toma C, Okura N, Takayama C, et al. Characteristic features of intracellular pathogenic Leptospira in infected murine macrophages. Cell Microbiol 2011; 13:1783-1792.
37. Li S, Ojcius DM, Liao S, et al. Replication or death: distinct fates of pathogenic Leptospira strain Lai within macrophages of human or mouse origin. Innate Immun 2010; 16:80-92.
38. Lacroix-Lamande S, d'Andon MF, Michel E, et al. Downregulation of the Na/KATPase pump by leptospiral glycolipoprotein activates the NLRP3 inflammasome. J Immunol 2012; 188:2805-2814.
39. Gaudart N, Ekpo P, Pattanapanyasat K, et al. Leptospira interrogans is recognized through DC-SIGN and induces maturation and cytokine production by human dendritic cells. FEMS Immunol Med Microbiol 2008; 53:359-367.
40. Naiman BM, Alt D, Bolin CA, et al. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gamma-delta T lymphocytes. Infect Immun 2001; 69:7550-7558.
41. Barry M, Wisnewski AV, Matthias MA, et al. Suburban leptospirosis: atypical lymphocytosis and gamma-delta T cell response. Clin Infect Dis 2006; 43: 1304-1307.
42. Chassin C, Picardeau M, Goujon JM, et al. TLR4-and TLR2-mediated B cell responses control the clearance of the bacterial pathogen, Leptospira interrogans. J Immunol 2009; 183:2669-2677.
43. Desai S, van Treeck U, Lierz M, et al. Resurgence of field fever in a temperate country: an epidemic of leptospirosis among seasonal strawberry harvesters in Germany in 2007. Clin Infect Dis 2009; 48:691-697.
44. Gonzalez Astudillo V, Wehdeking Hernandez D, Peña Stadlin J, et al. Comparative seroprevalence of Leptospira interrogans in Colombian mammals along a climatic gradient. J Zoo Wildl Med 2012; 43:768-775.
45. Ganoza CA, Matthias MA, Collins-Richards D, et al. Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med 2006; 3:e308.
46. Vital-Brazil JM, Balassiano IT, Oliveira FSD, et al. Multiplex PCR-based detection of Leptospira in environmental water samples obtained from a slum settlement. Memó rias do Instituto Oswaldo Cruz 2010; 105:353-355.
47. Tansuphasiri U, Thipsuk C, Phulsuksombati D, et al. Duplex PCR-hybridization based detection of pathogenic Leptospira in environmental water samples obtained from endemic areas in northeast region of Thailand. Southeast Asian J Trop Med Public Health 2006; 37:729-741.
48. Lau C, Jagals P. A framework for assessing and predicting the environmental health impact of infectious diseases: a case study of leptospirosis. Rev Environ Health 2012; 27:163-174.
49. Lau CL, Clements AC, Skelly C, et al. Leptospirosis in American Samoa: estimating and mapping risk using environmental data. PLoS Negl Trop Dis 2012; 6:e1669.
50. Nally JE, Monahan AM, Miller IS, et al. Comparative proteomic analysis of differentially expressed proteins in the urine of reservoir hosts of leptospirosis. PLoS One 2011; 6:e26046.
51. MonahanAM,CallananJJ, Nally JE. Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect Immun 2008; 76:4952-4958.
52. Eshghi A, Cullen PA, Cowen L, et al. Global proteome analysis of Leptospira interrogans. J Proteome Res 2009; 8:4564-4578.
53. Srivastava R, Ray S, Vaibhav V, et al. Serum profiling of leptospirosis patients to investigate proteomic alterations. J Proteomics 2012; 76:56-68.
54. Wieser A, Schneider L, Jung J, et al. MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Appl Microbiol Biotechnol 2012; 93:965-974.
55. Rettinger A, Krupka I, Grunwald K, et al. Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST). BMC Microbiol 2012; 12:185.